Niclas Björn

8PUBLICATIONS
18CO-AUTHORS
Predictive and prognostic markersMolecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Cheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 16, 2024
Prediction models of persistent taxane-induced peripheral neuropathy among breast cancer survivors using whole-exome sequencing.

Kristina Engvall, Hanna Uvdal, Niclas Björn

|Nov 15, 2022
Early changes in gene expression profiles in AML patients during induction chemotherapy.

Ingrid Jakobsen, Max Sundkvist, Niclas Björn

|Feb 08, 2022
The association of four genetic variants with myelosuppression in gemcitabine-treated Japanese is not evident in gemcitabine/carboplatin-treated Swedes.

Niclas Björn, Ingrid Jakobsen, Chihiro Udagawa

|Aug 26, 2020
Whole-genome sequencing and gene network modules predict gemcitabine/carboplatin-induced myelosuppression in non-small cell lung cancer patients.

Niclas Björn, Tejaswi Venkata Satya Badam, Rapolas Spalinskas

|Aug 05, 2020
Activation of the μ-opioid receptor by alicyclic fentanyls: Changes from high potency full agonists to low potency partial agonists with increasing alicyclic substructure.

Anna Åstrand, Svante Vikingsson, Ingrid Jakobsen

|May 20, 2020
Single-Cell RNA Sequencing of Hematopoietic Stem and Progenitor Cells Treated with Gemcitabine and Carboplatin.

Niclas Björn, Ingrid Jakobsen, Kourosh Lotfi

Pageof 2

Frequent Collaborators

6 joint publications

Henrik Gréen

5 joint publications

Ingrid Jakobsen Falk

2 joint publications

Hirsh Koyi

2 joint publications

Kourosh Lotfi